TCL Archive CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years April 16, 1999
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals April 18, 1986